Middle East & Africa Sarcopenia Treatment Market to 2032
Overview
The Middle East & Africa Sarcopenia Treatment Market is expected to reach a 86.06 USD Million by 2032 and is projected to grow at a CAGR of 3.09% from 2025 to 2032.
Revenue, 2024 (USD Million)
71.77
Forecast, 2032 (USD Million)
86.06
CAGR, 2024 - 2032
3.09%
Report Coverage
Middle East & Africa
Middle East & Africa Sarcopenia Treatment Market 2018-2032 USD Million
Middle East & Africa Sarcopenia Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 71.77 USD Million
- Projected Market Size (2032): 86.06 USD Million
- CAGR (2025-2032): 3.09%
Key Findings of Middle East & Africa Sarcopenia Treatment Market
- The Middle East & Africa Sarcopenia Treatment Market was valued at 71.77 USD Million in 2024.
- The Middle East & Africa Sarcopenia Treatment Market is likely to grow at a CAGR of 3.09% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 47.69 USD Million
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 3.95% during the forecast period from 2024 to 2032.
Middle East & Africa Sarcopenia Treatment Market Scope
Middle East & Africa Sarcopenia Treatment Market Segmentation & Scope
Treatment Type
- Others
- Medications1
- Vitamin/Dietary Supplements1
Type
- Secondary Sarcopenia
- Primary Sarcopenia
Stages
- Severe Sarcopenia
- Sarcopenia
- Pre-Sarcopenia
Route of Administration
- Others
- Injectables
- Oral
Gender
- Female
- Male
End User
- Others
- Home Healthcare
- Speciality Clinics
- Hospitals
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Middle East & Africa Sarcopenia Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 71.77 USD Million |
| Market Value in 2032 | 86.06 USD Million |
| CAGR (2025-2032) | 3.09% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Treatment Type,Type,Stages,Route of Administration,Gender,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 71.77 USD Million in 2024
- Key Country: South Africa, leading in terms of revenue with value of 13.79 USD Million in 2024.
Segments and Scope
-
Middle East & Africa Sarcopenia Treatment Market to 2032, By Treatment Type
- Vitamin/Dietary Supplements1 is the largest segment in Middle East & Africa Sarcopenia Treatment Market to 2032 with a revenue of 34.00 USD Million in the year 2024.
- Vitamin/Dietary Supplements1 is the Fastest growing segment in Middle East & Africa Sarcopenia Treatment Market to 2032 with a Growth rate of 3.70 % in forecast period 2025-2032.
-
Middle East & Africa Sarcopenia Treatment Market to 2032, By Type
- Primary Sarcopenia is the largest segment in Middle East & Africa Sarcopenia Treatment Market to 2032 with a revenue of 42.44 USD Million in the year 2024.
- Primary Sarcopenia is the Fastest growing segment in Middle East & Africa Sarcopenia Treatment Market to 2032 with a Growth rate of 3.62 % in forecast period 2025-2032.
-
Middle East & Africa Sarcopenia Treatment Market to 2032, By Stages
- Pre-Sarcopenia is the largest segment in Middle East & Africa Sarcopenia Treatment Market to 2032 with a revenue of 33.16 USD Million in the year 2024.
- Pre-Sarcopenia is the Fastest growing segment in Middle East & Africa Sarcopenia Treatment Market to 2032 with a Growth rate of 3.86 % in forecast period 2025-2032.
-
Middle East & Africa Sarcopenia Treatment Market to 2032, By Route of Administration
- Oral is the largest segment in Middle East & Africa Sarcopenia Treatment Market to 2032 with a revenue of 40.64 USD Million in the year 2024.
- Oral is the Fastest growing segment in Middle East & Africa Sarcopenia Treatment Market to 2032 with a Growth rate of 3.73 % in forecast period 2025-2032.
-
Middle East & Africa Sarcopenia Treatment Market to 2032, By Gender
- Male is the largest segment in Middle East & Africa Sarcopenia Treatment Market to 2032 with a revenue of 44.45 USD Million in the year 2024.
- Male is the Fastest growing segment in Middle East & Africa Sarcopenia Treatment Market to 2032 with a Growth rate of 3.53 % in forecast period 2025-2032.
-
Middle East & Africa Sarcopenia Treatment Market to 2032, By End User
- Hospitals is the largest segment in Middle East & Africa Sarcopenia Treatment Market to 2032 with a revenue of 38.51 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Middle East & Africa Sarcopenia Treatment Market to 2032 with a Growth rate of 3.95 % in forecast period 2025-2032.
-
Middle East & Africa Sarcopenia Treatment Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Middle East & Africa Sarcopenia Treatment Market to 2032 with a revenue of 47.69 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Middle East & Africa Sarcopenia Treatment Market to 2032 with a Growth rate of 3.39 % in forecast period 2025-2032.
Middle East & Africa Sarcopenia Treatment Market Company Share Analysis
| Company Name |
|
||
| Nestlé | |||
| Novartis AG | |||
| Sanofi | |||
| BASF SE | |||
| Abbott | |||
Middle East & Africa Sarcopenia Treatment Market Geographical Sales Distribution, 2018-2032 USD Million
Middle East & Africa Sarcopenia Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Sarcopenia Treatment Market is segmented based on Segmentation Treatment Type,Type,Stages,Route of Administration,Gender,End User,Distribution Channel.
Middle East & Africa Sarcopenia Treatment Market was valued at USD 71.77(Revenue in USD Million) in 2021.
Middle East & Africa Sarcopenia Treatment Market is projected to grow at a CAGR of 3.09% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the Middle East & Africa Sarcopenia Treatment Market, holding a largest market share of 47.69 USD Million in 2024
Middle East & Africa Sarcopenia Treatment Market Scope
Middle East & Africa Sarcopenia Treatment Market Segmentation & Scope
Treatment Type
- Others
- Medications1
- Vitamin/Dietary Supplements1
Type
- Secondary Sarcopenia
- Primary Sarcopenia
Stages
- Severe Sarcopenia
- Sarcopenia
- Pre-Sarcopenia
Route of Administration
- Others
- Injectables
- Oral
Gender
- Female
- Male
End User
- Others
- Home Healthcare
- Speciality Clinics
- Hospitals
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Frequently Asked Questions
The Middle East & Africa Sarcopenia Treatment Market is segmented based on Segmentation Treatment Type,Type,Stages,Route of Administration,Gender,End User,Distribution Channel.
Middle East & Africa Sarcopenia Treatment Market was valued at USD 71.77(Revenue in USD Million) in 2021.
Middle East & Africa Sarcopenia Treatment Market is projected to grow at a CAGR of 3.09% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Sarcopenia Treatment Market for final year is USD 86.06 (USD Million).
Middle East & Africa Sarcopenia Treatment Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Sarcopenia Treatment Market is segmented based on Segmentation Treatment Type,Type,Stages,Route of Administration,Gender,End User,Distribution Channel.
Middle East & Africa Sarcopenia Treatment Market was valued at USD 71.77(Revenue in USD Million) in 2021.
Middle East & Africa Sarcopenia Treatment Market is projected to grow at a CAGR of 3.09% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Sarcopenia Treatment Market for final year is USD 86.06 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.